SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-010219
Filing Date
2015-11-09
Accepted
2015-11-09 17:05:14
Documents
13
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imuc-10q_20150930.htm 10-Q 738585
2 EX-10.1 imuc-ex101_15.htm EX-10.1 49146
3 EX-10.2 imuc-ex102_16.htm EX-10.2 56941
4 EX-31.1 imuc-ex311_12.htm EX-31.1 15731
5 EX-31.2 imuc-ex312_7.htm EX-31.2 15768
6 EX-32.1 imuc-ex321_9.htm EX-32.1 7227
7 EX-32.2 imuc-ex322_8.htm EX-32.2 7211
  Complete submission text file 0001564590-15-010219.txt   3639567

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT imuc-20150930.xml EX-101.INS 510325
9 XBRL TAXONOMY EXTENSION SCHEMA imuc-20150930.xsd EX-101.SCH 42039
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imuc-20150930_cal.xml EX-101.CAL 32900
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imuc-20150930_def.xml EX-101.DEF 121739
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE imuc-20150930_lab.xml EX-101.LAB 319561
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imuc-20150930_pre.xml EX-101.PRE 233146
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35560 | Film No.: 151216553
SIC: 2834 Pharmaceutical Preparations